Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2026-01-22 @ 10:51 PM
Study NCT ID:
NCT04230304
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-03
First Post:
2020-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-10-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-13
First Submit QC Date:
None
Study First Post Date:
2020-01-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-05-19
Results First Submit QC Date:
None
Results First Post Date:
2025-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-29
Last Update Post Date:
2025-11-03
Last Update Post Date Type:
ESTIMATED